Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Nextech Invest Ltd.
Form 13F · Q2 2026

Nextech Invest Ltd.

CIK 1595430Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$2.1B
Reported book value
16
Positions
6
Quarters on record
Top 50
Positions

Nextech Invest Ltd. — holdings

Top 15 positions of 16, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1RVMD Revolution Medicines Inc7.6M+0.0%$1.4B67.6%
2PBLS Parabilis Medicines Inc4.7M—$128M6.1%
3RLAY Relay Therapeutics Inc6.8M+22.6%$127M6.0%
4TYRA Tyra Biosciences Inc3.6M−12.4%$114M5.4%
5ALMS Alumis Inc3.5M+0.0%$100M4.7%
6ORIC Oric Pharmaceuticals Inc7.2M+0.0%$78M3.7%
7KYMR Kymera Therapeutics Inc278,896+0.0%$32M1.5%
8ZYME Zymeworks Inc1.1M+0.0%$29M1.4%
9GLUE Monte Rosa Therapeutics Inc761,153+150.2%$18M0.9%
10ARVN Arvinas Inc1.1M+108.1%$17M0.8%
11CTMX Cytomx Therapeutics Inc.4.4M+0.0%$17M0.8%
12SLN Silence Therapeutics Plc952,400+0.0%$10M0.5%
13CRVS Corvus Pharmaceuticals Inc450,000+0.0%$7M0.3%
14CNTX Context Therapeutics Inc7.4M+0.0%$4M0.2%
15ENGN Engene Therapeutics Inc2.3M—$4M0.2%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.